Concepedia
Statistics
Publications
18
Citations
987
H-Index
14
Active since
1995
Affiliations
Novartis (France)(Current)
Inserm
Centre Hospitalier Universitaire de Bordeaux
Université de Bordeaux
Bordeaux Population Health
Vincent Gros is an author at Novartis (France) specializing in pharmacotherapy, pharmacology, and pharmacy.
Publications per year
1995–2018
Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
Marc Humbert, Camille Taillé, Laurence Mala et al. · European Respiratory Journal · 2018 · 270 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +16
Effectiveness of omalizumab (Xolair®) in the first patients treated in real-life practice in France
Mathiéu Molimard, F. de Blay, A. Didier et al. · Respiratory Medicine · 2007 · 99 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +4
Omalizumab-induced decrease of FcɛRI expression in patients with severe allergic asthma
Pascal Chanez, Cécile Contin‐Bordes, Gilles Garcia et al. · Respiratory Medicine · 2010 · 84 citations · Full text
Life Sciences, Immunology, Pharmacology +15
Impact of Patient-Related Factors on Asthma Control
Mathiéu Molimard, Vincent Gros · Journal of Asthma · 2008 · 81 citations
Pharmacy, Pharmacotherapy, Electronic Health Records +8
Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data
Mathiéu Molimard, Roland Buhl, Robert Niven et al. · Respiratory Medicine · 2010 · 79 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +16
1–5 of 18